Is COVID going around in France?
COVID-19: Low
No. COVID activity in France is currently low and rising (as of 11 Oct 2026).
Data window: Week 41 · Oct 5 – Oct 11 · Source: ECDC (weekly) · Next update Fri, Oct 23
Get one free alert when the wave turns in France
We write exactly once: the moment the level goes up. No account, no newsletter. We store your address and the country, nothing else. Every mail has a one click unsubscribe. Privacy
Current activity
Source: ECDC ERVISS, ECDC Data. Published weekly, about one week behind.
Frequently asked questions
How is COVID-19 monitored in France today?
COVID-19 surveillance in France is now embedded in the broader respiratory-infection monitoring run by Santé publique France. Indicators include SOS Médecins consultations, OSCOUR emergency visits, SIVIC hospital and ICU admissions, sentinel virological testing, and variant characterisation by the Centre national de référence des virus des infections respiratoires. Results are published weekly and also contribute to the ECDC ERVISS dashboard.
Is COVID-19 still dangerous in France?
COVID-19 is now endemic in France and continues to cause hospitalisations and deaths each winter, concentrated in older adults and people with weakened immune systems. Thanks to vaccination and prior infections, most people experience an illness closer to flu or a bad cold. Long COVID remains under study and is followed through dedicated health surveys. Risk is managed through targeted boosters rather than general restrictions.
When do COVID-19 waves happen in France?
So far, COVID-19 in France has not settled into a strict single-season rhythm like influenza. A winter wave overlapping with flu and RSV has been the most consistent pattern, but summer and spring waves have also occurred when new variants emerged with a clear immune-escape advantage. Variant surveillance is therefore watched alongside hospitalisations for early warning of a resurgence.
Who is eligible for a COVID-19 booster in France?
France runs autumn COVID-19 booster campaigns targeted at groups advised by the Haute Autorité de Santé, typically including adults aged 65 and over, people with comorbidities, pregnant women, residents of medical and social institutions, and healthcare workers. Vaccines are available in pharmacies, GP practices, and vaccination centres. Santé publique France publishes uptake data alongside weekly surveillance.
Are new variants still a concern?
SARS-CoV-2 continues to evolve, and new sublineages are detected by routine French sequencing coordinated by the national reference centre. Most emerging variants cause illness broadly comparable to their predecessors, but lineages with clear immune escape can drive faster and larger waves. Santé publique France reports variant trends in its respiratory-infection bulletins and via the ECDC ERVISS platform.